Smith Nicholas Conradinsider trades
In SEC Form 4 filings, Smith Nicholas Conrad is listed as PRESIDENT AND CFO of Alto Neuroscience, Inc. (ANRO). In the last 90 days, Smith Nicholas Conrad sold $3.57M of Alto Neuroscience, Inc. (ANRO) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ANROAlto Neuroscience, Inc. | PRESIDENT AND CFO | 11 | Oct 5 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ANROAlto Neuroscience, Inc. | Oct 2 | Oct 5 | M | 55,000 | $2.32 | $127,600 | 79,060 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Oct 2 | Oct 5 | M · derivative | 55,000 | $2.32 | $127,600 | 57,405 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Sep 30 | Oct 1 | M | 24,056 | $2.35 | $56,532 | 48,116 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Sep 30 | Oct 1 | S | 23,170 | $25.78 | Sale −$597,290 | 24,946 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Sep 30 | Oct 1 | S | 886 | $26.87 | Sale −$23,807 | 24,060 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Sep 30 | Oct 1 | M · derivative | 24,056 | $2.35 | $56,532 | 121,818 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Sep 29 | Oct 1 | M | 56,455 | $2.35 | $132,669 | 80,515 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Sep 29 | Oct 1 | M | 54,375 | $2.35 | $127,781 | 134,890 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Sep 29 | Oct 1 | S | 110,830 | $26.58 | Sale −$2,946,150 | 24,060 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Sep 29 | Oct 1 | M · derivative | 56,455 | $2.35 | $132,669 | 145,874 | No | Form 4 |
| ANROAlto Neuroscience, Inc. | Sep 29 | Oct 1 | M · derivative | 54,375 | $2.35 | $127,781 | 35,625 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.